News

Neuren Pharmaceuticals (ASX:NEU) Records 594% Jump in 1HFY24 Royalty Revenue, Expects Continued Growth in FY24

Neuren Pharmaceuticals Limited (ASX:NEU), an ASX-listed biopharmaceutical company focused on neurological disorder treatments, has reported significant financial and regulatory developments. Recently, the company has experienced substantial growth in royalty revenue, strengthened its partnership with Acadia Pharmaceuticals, and is advancing clinical trials for NNZ-2591.

Team Kalkine | 12 February 2025

FireFly Metals (ASX:FFM) Soars 112% in a Year On Resource Growth and Key Developments

An emerging copper-gold company, FireFly Metals Ltd (ASX:FFM) has seen its share price surge by over 112% in the past year, driven by significant resource expansion and encouraging drilling results at its Green Bay copper-gold project in Newfoundland, Canada.

Team Kalkine | 11 February 2025

CSL (ASX:CSL) Eyes Double-Digit Earnings Growth in FY25: What’s Driving the Momentum?

CSL Limited (ASX:CSL) is an ASX-listed global biopharmaceutical company. The company achieved an 11% YoY jump in its total revenue in the fiscal year ended 30 June 2024 (FY24), reaching USD 14.8 billion. Net Profit After Tax (NPAT) during the year surged by 20% …

Team Kalkine | 10 February 2025

Worley (ASX:WOR) Reports 243% Surge in Profit Before Tax for FY24, EPS Jumps 7%

Worley Limited (ASX:WOR) is a provider of professional services to the energy, chemicals, and resources sectors. Since July 2021, the company has secured nearly AU$7.6 billion in contracts across carbon capture, battery materials and low-carbon hydrogen sectors. Notably, a 99% normalised cash conversion rate …

Team Kalkine | 05 February 2025

Qualitas (ASX:QAL) Eyes FY25 Growth with Estimated Profit of AUD 49-55 Million

Qualitas Limited (ASX:QAL) is an alternative real estate investment management company in Australia and has reported a record net capital inflow of AUD 2.8 billion in the financial year 2024 (FY24), which increased its total committed funds under management (FUM) to AUD 8.9 billion. …

Team Kalkine | 04 February 2025

Betashares Crude Oil ETF (ASX: OOO): Easy Access to Oil Futures with Over 10% Return in Past Year

TheBetashares Crude Oil Index Currency Hedged Complex ETF (ASX: OOO)provides investors with exposure to crude oil futures, specifically tracking the performance of West Texas Intermediate (WTI) crude oil. This exchange traded fund is ideal for those looking to diversify their portfolios with oil price …

Team Kalkine | 04 February 2025

Cettire (ASX:CTT) Sees 78% Revenue Growth in FY24, Eyes Future Growth with Expanding Luxury Market

Cettire Limited (ASX:CTT) is an ASX-listed global luxury online retailer which is focused on expanding its presence in the high-end fashion market. For the 12 months ended 30 June 2024 (FY24), Cettire reported a 78% YoY increase in sales revenue, reaching AUD 742.25 million. …

Team Kalkine | 03 February 2025

Australian Ethical Investment (ASX:AEF) Sees Revenue and Profit Surge in FY24, Eyes Growth in FY25

Australian Ethical Investment Limited (ASX:AEF)is an ASX-listed ethical investment manager which has witnessed significant revenue and profit growth in the financial year 2024 (FY24).

Team Kalkine | 30 January 2025

Iluka (ASX:ILU) Streamlines Operations with Cost-Cutting Measures, Set to Save AUD20Mn in 2025

Iluka Resources Ltd (ASX:ILU), an Australian-based mineral sands company, is engaged in the project development, exploration, processing, mining and marketing of zircon and titanium dioxide feedstocks.

Team Kalkine Media | 29 January 2025

Super Retail Group (ASX:SUL) Plans AUD165M Investment to Drive Digital & Retail Expansion

Super Retail Group Limited (ASX:SUL), a major Australian retailer specialising in auto parts, outdoor equipment, and sporting goods, released its financial results for the financial year 2024 (FY24). Despite rising living costs impacting discretionary spending, the company managed to achieve a 2.10% YoY increase …

Team Kalkine | 28 January 2025